Metabolic modulation of acute myocardial infarction.
Acute myocardial infarction continues to be the major determinant of death and disability in Western countries. Despite large improvements in management during the last 20 years, its high morbidity and mortality rates provide a stimulus to search intensively for different and widely applicable therapeutic options.
Diaz
R
R
Estudios Cardiologicos Latinoamerica, Instituto Cardiovascular de Rosario, Rosario, Argentina.
D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005947:Glucose / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism / Q000627:therapeutic use*
D002314:Cardioplegic Solutions; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium